Pro-Dex (NASDAQ: PDEX)
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-25 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.330 | 0.120 | -0.2100 | ||||
REV | 10.920M | 9.265M | -1.655M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Pro-Dex (NASDAQ: PDEX) through any online brokerage.
Other companies in Pro-Dex’s space includes: Sonendo (NYSE:SONX), Second Sight Medical (NASDAQ:EYES), LENSAR (NASDAQ:LNSR), Vapotherm (NYSE:VAPO) and Modular Medical (NASDAQ:MODD).
The latest price target for Pro-Dex (NASDAQ: PDEX) was reported by Ascendiant Capital on Wednesday, January 4, 2017. The analyst firm set a price target for 7.00 expecting PDEX to fall to within 12 months (a possible -55.70% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Pro-Dex (NASDAQ: PDEX) is $15.8 last updated Today at July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Pro-Dex.
Pro-Dex’s Q4 earnings are confirmed for Thursday, August 25, 2022.
There is no upcoming split for Pro-Dex.
Pro-Dex is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.